NOF Corporation
NOF Corporation manufactures chemicals Japan, rest of Asia, and internationally. The company operates through Functional Chemicals, Life Science, and Explosive & Propulsion segments. The Functional Chemicals segment offers fatty acids and glycerin, fatty acid derivatives, and surfactants, ethylene oxide and propylene oxide derivatives, organic peroxides, functional polymers, functional films, and… Read more
NOF Corporation (NOF) - Net Assets
Latest net assets as of September 2025: €283.15 Billion EUR
Based on the latest financial reports, NOF Corporation (NOF) has net assets worth €283.15 Billion EUR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€377.59 Billion) and total liabilities (€94.44 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €283.15 Billion |
| % of Total Assets | 74.99% |
| Annual Growth Rate | 8.37% |
| 5-Year Change | 37.36% |
| 10-Year Change | N/A |
| Growth Volatility | 4.06 |
NOF Corporation - Net Assets Trend (2016–2025)
This chart illustrates how NOF Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for NOF Corporation (2016–2025)
The table below shows the annual net assets of NOF Corporation from 2016 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | €279.55 Billion | +5.13% |
| 2024-03-31 | €265.91 Billion | +10.79% |
| 2023-03-31 | €240.00 Billion | +8.25% |
| 2022-03-31 | €221.70 Billion | +8.94% |
| 2021-03-31 | €203.51 Billion | +13.88% |
| 2020-03-31 | €178.72 Billion | +0.24% |
| 2019-03-31 | €178.28 Billion | +5.14% |
| 2018-03-31 | €169.57 Billion | +11.15% |
| 2017-03-31 | €152.56 Billion | +12.48% |
| 2016-03-31 | €135.63 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to NOF Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 145.4% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €220.19 Billion | 79.06% |
| Other Components | €58.33 Billion | 20.94% |
| Total Equity | €278.53 Billion | 100.00% |
NOF Corporation Competitors by Market Cap
The table below lists competitors of NOF Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
4DMEDICAL Ltd
AU:4DX
|
$1.03 Billion |
|
Baoding Lucky Innovative Materials Co Ltd
SHE:300446
|
$1.03 Billion |
|
Anhui Xinlong Electrical Co Ltd
SHE:002298
|
$1.03 Billion |
|
Iovance Biotherapeutics Inc
NASDAQ:IOVA
|
$1.03 Billion |
|
Pennant Group Inc
NASDAQ:PNTG
|
$1.03 Billion |
|
Poya International Co Ltd
TWO:5904
|
$1.03 Billion |
|
SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares
NASDAQ:HDL
|
$1.03 Billion |
|
National Energy Services Reunited Corp Ordinary Shares
NASDAQ:NESR
|
$1.03 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in NOF Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 265,002,000,000 to 278,527,000,000, a change of 13,525,000,000 (5.1%).
- Net income of 36,497,000,000 contributed positively to equity growth.
- Dividend payments of 9,593,000,000 reduced retained earnings.
- Share repurchases of 12,012,000,000 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €36.50 Billion | +13.1% |
| Dividends Paid | €9.59 Billion | -3.44% |
| Share Repurchases | €12.01 Billion | -4.31% |
| Other Changes | €-1.37 Billion | -0.49% |
| Total Change | €- | 5.10% |
Book Value vs Market Value Analysis
This analysis compares NOF Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.01x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-03-31 | €1753.42 | €14.81 | x |
| 2018-03-31 | €1980.10 | €14.81 | x |
| 2019-03-31 | €2108.75 | €14.81 | x |
| 2020-03-31 | €2140.97 | €14.81 | x |
| 2021-03-31 | €2448.59 | €14.81 | x |
| 2022-03-31 | €896.87 | €14.81 | x |
| 2023-03-31 | €986.84 | €14.81 | x |
| 2024-03-31 | €1109.00 | €14.81 | x |
| 2025-03-31 | €1192.67 | €14.81 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently NOF Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 13.10%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 15.31%
- • Asset Turnover: 0.67x
- • Equity Multiplier: 1.28x
- Recent ROE (13.10%) is above the historical average (12.15%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 10.08% | 7.97% | 0.87x | 1.46x | €105.00 Million |
| 2017 | 11.59% | 10.10% | 0.80x | 1.43x | €2.41 Billion |
| 2018 | 11.80% | 11.07% | 0.76x | 1.41x | €3.03 Billion |
| 2019 | 12.41% | 11.65% | 0.77x | 1.38x | €4.28 Billion |
| 2020 | 11.88% | 11.68% | 0.77x | 1.32x | €3.35 Billion |
| 2021 | 11.49% | 13.50% | 0.64x | 1.34x | €3.02 Billion |
| 2022 | 12.08% | 13.85% | 0.67x | 1.31x | €4.60 Billion |
| 2023 | 14.20% | 15.60% | 0.70x | 1.29x | €10.06 Billion |
| 2024 | 12.83% | 15.29% | 0.65x | 1.29x | €7.49 Billion |
| 2025 | 13.10% | 15.31% | 0.67x | 1.28x | €8.64 Billion |
Industry Comparison
This section compares NOF Corporation's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $18,803,803,535
- Average return on equity (ROE) among peers: -24.22%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| NOF Corporation (NOF) | €283.15 Billion | 10.08% | 0.33x | $1.03 Billion |
| Kureha Corporation (0K1) | $162.17 Billion | 8.59% | 0.53x | $845.56 Million |
| Polwax S.A (1LW) | $54.23 Million | -71.97% | 1.06x | $3.33 Million |
| H&R GmbH & Co. KGaA (2HRA) | $287.13 Million | 9.37% | 1.19x | $34.48 Million |
| Renaissance Oil Corp (2R7) | $2.68 Billion | 6.64% | 1.08x | $1.31 Billion |
| Global New Material International Holdings Limited (69Y) | $4.35 Billion | 5.56% | 0.62x | $625.83 Million |
| Altech Chemicals Ltd (A3Y) | $33.88 Million | -176.29% | 0.32x | $18.88 Million |
| Beijing Media Corporation Limited (BME) | $1.20 Billion | -7.10% | 0.16x | $1.77 Million |
| BRAIN Biotech AG (BNN) | $17.59 Million | -23.28% | 0.43x | $40.42 Million |
| Brenntag SE (BNR) | $2.69 Billion | 13.57% | 1.59x | $5.87 Billion |
| Huabao International Holdings Limited (CEY) | $14.56 Billion | -7.24% | 0.14x | $1.44 Billion |